Effect of an Unsupervised Multi-domain Intervention on Injury Risk Reduction in Athletics (I-ReductAI).
NCT ID: NCT06805162
Last Updated: 2025-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
643 participants
INTERVENTIONAL
2025-02-07
2025-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Injury Risk Factors in Elite Athletes
NCT06906666
Autonomic Nervous System, Fatigue and Intolerance to Physical Training, and Overtraining in High-Level Athletes
NCT01463761
To Evaluate the Effectiveness of an Injury Prevention Program in Athletics
NCT03307434
Fitness- and Health-related Effects of a Sports Injury Prevention Program in Competitive Alpine Skiers
NCT04021576
Analytic, Prospective Cohort Study of Athletes Enrolled in an Exercise Training Intervention
NCT02999139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Specific training
there will be a multi-domain intervention: i) A series of 12 educational videos on injury prevention; ii) Neuro-muscular exercise-based injury prevention programmes; iii) Techniques against stress and anxiety through breathing and mindfulness practice; iv) Injury prognostic feedback using individual data and based on a machine learning model.
Specific training
Athletes should consider i) watching the educational videos on injury prevention, ii) perform the neuro-muscular exercises, iii) practice the techniques against stress and anxiety, and iv) consider the injury prognostic feedback.
Normal training
Athletes who continue their normal training
Normal training
Athletes should continue their normal training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal training
Athletes should continue their normal training
Specific training
Athletes should consider i) watching the educational videos on injury prevention, ii) perform the neuro-muscular exercises, iii) practice the techniques against stress and anxiety, and iv) consider the injury prognostic feedback.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have daily access to a digital device (smartphone, computer, tablet) with a network connection (public or private).
Exclusion Criteria
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint Etienne School of Mine
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PASCAL EDOUARD, MD-PHD
Role: PRINCIPAL_INVESTIGATOR
CENTRE HOSPITALIER DE SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24CH262
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.